Zacks Small-Cap Research Initiates Coverage on NewGen
NewGen (NASDAQ:NIVF) announced that Zacks Small-Cap Research initiated equity research coverage on October 10, 2025. The announcement notes NewGen is a tech-forward, multi-jurisdictional growth company operating in real estate development, digital asset management and reproductive health solutions. The full Zacks equity research report is available on the Zacks website.
NewGen (NASDAQ:NIVF) ha annunciato che Zacks Small-Cap Research ha avviato la copertura di ricerca azionaria il 10 ottobre 2025. L'annuncio sottolinea che NewGen è una società di crescita tecnologicamente avanzata, operante in sviluppo immobiliare, gestione di asset digitali e soluzioni per la salute riproduttiva, presente in più giurisdizioni. Il rapporto completo di ricerca azionaria di Zacks è disponibile sul sito web di Zacks.
NuevaGen (NASDAQ:NIVF) anunció que Zacks Small-Cap Research inició la cobertura de investigación de acciones el 10 de octubre de 2025. El anuncio señala que NuevaGen es una empresa de crecimiento tecnológico, multicjurisdiccional, que opera en desarrollo inmobiliario, gestión de activos digitales y soluciones de salud reproductiva. El informe completo de investigación sobre acciones de Zacks está disponible en el sitio web de Zacks.
NewGen (NASDAQ:NIVF)는 2025년 10월 10일 Zacks Small-Cap Research가 주식 연구 커버리지에 착수했다고 발표했습니다. 발표에 따르면 NewGen은 기술 주도형 다관할 성장 기업으로서 부동산 개발, 디지털 자산 관리 및 생식 건강 솔루션 분야에서 활동하고 있습니다. Zacks의 전체 주식 연구 보고서는 Zacks 웹사이트에서 확인할 수 있습니다.
NewGen (NASDAQ:NIVF) a annoncé que Zacks Small-Cap Research a lancé la couverture de recherche sur les actions le 10 octobre 2025. L'annonce indique que NewGen est une entreprise de croissance axée sur la technologie et opérant dans plusieurs juridictions, active dans développement immobilier, gestion d'actifs numériques et solutions de santé reproductive. Le rapport de recherche sur les actions complet de Zacks est disponible sur le site Web de Zacks.
NewGen (NASDAQ:NIVF) kündigte an, dass Zacks Small-Cap Research am 10. Oktober 2025 die Aktienforschungsabdeckung aufgenommen hat. Die Ankündigung macht deutlich, dass NewGen ein technologieorientiertes, grenzüberschreitend tätiges Wachstumsunternehmen ist und in Immobilienentwicklung, digitale Vermögensverwaltung und Lösungen für reproduktive Gesundheit tätig ist. Der vollständige Zacks-Aktienforschungsbericht ist auf der Zacks-Website verfügbar.
NewGen (NASDAQ:NIVF) أعلنت Zacks Small-Cap Research أنها بدأت تغطية أبحاث الأسهم في 10 أكتوبر 2025. وذكر الإعلان أن نيوجين هي شركة نمو مدفوعة بالتكنولوجيا وتعمل في تطوير العقارات، إدارة الأصول الرقمية و حلول الصحة الإنجابية في عدة ولايات قضائية. يمكن العثور على التقرير الكامل لأبحاث أسهم Zacks على موقع Zacks الإلكتروني.
NewGen (NASDAQ:NIVF) 宣布 Zacks Small-Cap Research 于 2025 年 10 月 10 日启动股票研究覆盖。公告指出,NewGen 是一家以科技为驱动、跨多法域运营的增长型公司,业务涵盖 房地产开发、数字资产管理 和 生殖健康解决方案。Zacks 的完整股票研究报告可在 Zacks 网站上查阅。
- None.
- None.
BANGKOK, Oct. 10, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced that Zacks Small-Cap Research ("Zacks") has initiated equity research coverage on the Company. The full equity research report is available on the Zacks website here.
About NewGen
NewGenIVF Group is a tech-forward, diversified, multi-jurisdictional high-growth entity capitalizing on emerging opportunities across real estate development, digital asset innovation and reproductive health solutions. The Company operates through three strategic business divisions that leverage cutting-edge technology and innovative solutions to drive sustainable growth and high ROI for shareholders across multiple global markets. These include “NewGenProperty”, which operates lucrative real estate development projects in the UAE's Ras Al Khaimah Emirate; “NewGenDigital”, which serves as the Company's digital asset and DeFi solutions arm; and "NewGenSup”, which focuses on health and longevity products and solutions. NewGen’s legacy business involves providing industry-leading IVF and assisted reproductive treatment services across Asia. With operations spanning multiple jurisdictions and a commitment to innovative, technology-enabled solutions, NewGenIVF Group is uniquely positioned to capitalize on the convergence of real estate, healthcare and digital asset opportunities in the evolving global economy.
To learn more, visit www.newgenivf.com. The information contained on, or accessible through, NewGen’s website is not incorporated by reference into this press release, and you should not consider it a part of this press release.
Investor Relations Contact
ICR, LLC
Robin Yang
Phone: +1 (212) 537-4406
Email: Newgenivf.IR@icrinc.com
